KRAS and colorectal carcinoma: Promising results have also been reported in cholangiocarcinoma after infusion with CD4+ T cells that recognized the Erbb2 binding protein ERBB2IP epitope [304] and HLA-C*8:02 in restricted KRAS G12D lung metastasis CRC [305].